Eton Pharmaceuticals, Inc.
Institutional holders · 13F as of Mar 31, 2026
| Holder | Value | % of shares |
|---|---|---|
| PRELUDE CAPITAL MANAGEMENT, LLC | $4.66M | 0.69% |
| OBERWEIS ASSET MANAGEMENT INC | $7.29M | 1.57% |
| BNP PARIBAS FINANCIAL MARKETS | $7.46M | 1.10% |
| Westside Investment Management, Inc. | $7.96M | 1.72% |
| Morgan Stanley | $8.35M | 1.80% |
| CANNELL CAPITAL LLC | $8.44M | 1.25% |
| GEODE CAPITAL MANAGEMENT, LLC | $14.26M | 2.11% |
| Nantahala Capital Management, LLC | $19.89M | 4.29% |
| VANGUARD GROUP INC | $22.81M | 4.92% |
| STATE STREET CORPORATION | $25.40M | 2.56% |
| EcoR1 Capital, LLC | $34.34M | 7.41% |
| Opaleye Management Inc. | $48.36M | 10.44% |
| BlackRock, Inc. | $68.63M | 6.92% |